mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.004 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.008 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
0.009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |